Evaluation of intravenous lorazepam dosing strategies and the incidence of refractory status epilepticus.

Introduction: Status epilepticus (SE) is a neurological emergency associated with high mortality if not identified and treated promptly. For the emergent treatment of SE, the recommended intravenous (IV) lorazepam dose is 0.1 mg/kg/dose, up to a maximum of 4 mg.